We have reported that the presence of CAFs expressing PDPN is a predictor of a poor prognosis among patients with lung adenocarcinoma and squamous cell carcinoma of the lung, [22–25] and PDPN itself has been shown to exert tumor-promoting effects using in vitro and in vivo models. The gene discussed is PDPN; the disease is lung adenocarcinoma.